SpheroSelect: Testing of new cancer drugs on tumor organoids on behalf of pharmaceutical companies
CompanySpheroTec GmbH, Martinsried, Germany
SpheroSelect is a division of Spherotec GmbH in Martinsried near Munich. The scientists at SpheroSelect are commissioned by pharmaceutical and biotech companies with the company's proprietary spheroid microtumor technology to test the mode of action of drug candidates for oncology. The three-dimensional cell culture systems from SpheroSelect allow a realistic functional oncological testing.
SpheroSelect: Für ein realitätsnahes Drugprofiling
Barbara Mayer
Added on: 05-22-2020
[1] https://www.spherotec.com/